Annoroad, headquartered in Beijing, is the China’s leading developer and marketer on genomic innovation technologies for research and clinical market. Based on its top throughput NGS sequencing center and cloud-based bioinformatics platform , Annoroad is offering service and products for customers from hospitals and research organizations. Please visit us at en.annoroad.com (clinical), en.genome.cn (research).
Company Details
- Employees
- 28
- Founded
- -
- Address
- B2, Yizhuang Biomedical Park, Kechuang 6 Rd, Beijing Economic-Technological Development Area, Beijing,beijing 100176,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.annoroad.com
- Keywords
- Non-invasive prenatal DNA testing, ctDNA testing, Companion Diagnostics, sequencing service, Diagnostic kit, Hi-C, Oncology, single cell sequencing, NextSeq 550AR, cloud computing.
- HQ
- Beijing, Beijing
Annoroad Genomics Questions
Annoroad Genomics's website is http://www.annoroad.com
Annoroad Genomics's LinkedIn profile is https://cn.linkedin.com/company/annoroad
Annoroad Genomics has
28 employees.
View email and phone details for 28
employees at Annoroad Genomics.
Annoroad Genomics's industry is
Biotechnology Research
Annoroad Genomics's top competitors are
Topgen Health Care Pvt. Ltd. / T. G. Pharma,
Validity Genetics - Paternity And Dna Services,
Neogenestar Llc,
Interpretbio,
Berry Genomics Co., Ltd.,
Novo Nordisk,
The Schinzel-Giedion Syndrome Foundation,
Berry Genomics,
Ravgen,
Chinapeptides Co.,ltd.(Qyaobio)强耀生物.
Annoroad Genomics's categories are Biotechnology Research
Annoroad Genomics's founding year is 2012
